【摘要】 目的探讨腹主动脉瘤腔内修复术的中远期治疗效果。方法对2006年8月至2020年3月170例腹主动脉瘤腔内修复术(EVAR)患者进行随访总结,并对围手术期病死率、中远期全因病死率、中远期并发症率和二次手术干预率等指标进行分析。结果 170例中136例得到随访,失访34例,随访率为80%,随访最长13年6个月,最短6个月。随访期内全因死亡20例,病死率11.8%(20/170)。其中围手术期死亡3例,病死率为1.8%(3/170)。与AAA有关死亡5例,病死率3.7%(5/136)。术后发生与AAA相关并发症15例,并发症发生率11.0%(15/136),其中再次干预9例,再次干预率6.6%。结论随着对EVAR并发症认识的深入,操作水平的不断提高以及器具的逐步完善,EVAR也能够达到较好的中远期治疗效果。更多还原

【Abstract】 Objective To investigate the long-term therapeutic effect of endovascular repair of abdominal aortic aneurysm(EVAR). Method Summarized 170 patients totally, who had EVAR surgery from August 2006 to March2020. Perioperative mortality, secondary surgical intervention, mid-and long-term complication rate and all-cause mortality were analyzed. Result Totally 170 patients included 136 were followed up and 34 lost, the follow-up rate was 80%, and the longest was 13 years and 6 months, the shortest was 6 months. The all-cause mortality was 11.8%(20/170), the perioperative mortality was 1.8%(3/170) and 5 death cases have been associated with abdominal aortic aneurysm(AAA), the mortality was 3.7%(5/136). AAA related complications occurred in 15 patients and the complication rate was 11.0%,included 9 patients had secondary surgical intervention, the rate was 6.6%. Conclusion With the deepening of the understanding of EVAR complications, the continuous improvement of the surgical skills and the gradual improvement of the equipment, EVAR can also achieve a better medium-and long-term therapeutic effect.更多还原